Center for Human and Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands.
Haematologica. 2013 May;98(5):691-5. doi: 10.3324/haematol.2012.065219. Epub 2012 Sep 14.
Genomic DNA of 3 patients, born as healthy carriers and developing a late-onset severe transfusion-dependent beta-thalassemia major was studied by high-density genome wide SNP array analysis. A mosaic loss of heterozygosity for almost the entire 11p was found, not attributable to deletions but involving mosaicism for segmental paternal isodisomy of 11p. Mitotic recombination leading to mosaic segmental uniparental isodisomy on chromosome 11p in multiple tissues has been described as a molecular disease mechanism for a subset of sporadic Beckwith-Wiedemann syndrome cases. A similar mechanism also seems to be involved in causing late-onset disease in carriers of recessive mutations in other genes located in 11p, such as late-onset beta-thalassemia major and sickle cell disease. We suggest that the loss of maternally imprinted IGF-2 and H19 genes may account for the selective advantage of hematopoietic cells containing this segmental paternal isodisomy of 11p carrying the β-thalassemia mutation.
对 3 名出生时为健康携带者、后发展为迟发性严重输血依赖型β地中海贫血的患者的基因组 DNA 进行了高密度全基因组 SNP 芯片分析。发现几乎整个 11p 存在杂合性丢失的镶嵌现象,这不是由于缺失引起的,而是涉及 11p 部分片段父源单亲二体性的镶嵌现象。在多种组织中,导致 11p 染色体着丝粒处镶嵌性片段单亲二体性的有丝分裂重组,已被描述为散发性贝克威思-威德曼综合征病例亚组的一种分子疾病机制。类似的机制似乎也与其他位于 11p 上的基因(如迟发性β地中海贫血和镰状细胞病)的隐性突变携带者的迟发性疾病有关。我们认为,母源印记的 IGF-2 和 H19 基因的缺失可能解释了携带β地中海贫血突变的、含有该 11p 片段父源单亲二体性的造血细胞具有选择性优势的原因。